Browsing by author "Morton, Rachael L"
Sort by:
Title A-Z
-
Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: a decision analysis
Wyld, ML; Clayton, PA; Morton, Rachael L; Chadban, SJPublished 2013-12-01BACKGROUND: Optimal treatment of atrial fibrillation (AF) in the haemodialysis population is uncertain due to the exclusion of this group from randomized trials. The risk-benefit profile for anticoagulation and anti-platelet ...Open AccessArticle -
Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis
Wyld, M; Clayton, P; Morton, Rachael L; Chadban, SPublished 2013-11-26NoneOpen AccessArticle -
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF) A Pilot Randomized Clinical Trial
Ackermann, Deonna M; Dieng, Mbatho; Medcalf, Ellie; Jenkins, Marisa C; van Kemenade, Cathelijne H; Janda, Monika; Turner, Robin M; Cust, Anne E; Morton, Rachael L; Irwig, Les; Guitera, Pascale; Soyer, Peter; Mar, Victoria; Hersch, Jolyn; Low, Donald; Low, Cynthia; Saw, Robyn P. M; Scolyer, Richard A; Drabarek, Dorothy; Espinoza, David; Azzi, Anthony; Lilleyman, Alister M; Smit, Amelia K; Murchie, Peter; Thompson, John F; Bell, Katy J.L.Published 2022Patient-led surveillance is a promising new model of follow-up care following excision of localized melanoma. Objective To determine whether patient-led surveillance in patients with prior localized primary cutaneous ...Open AccessArticle -
Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow Up? A Protocol for the MELSELF Randomised Controlled Trial.
Ackermann, Deonna; Smit, Amelia K; Janda, Monika; van Kemenade, Cathelijne; Dieng, Mbathio; Morton, Rachael L; Turner, Robin M; Cust, Anne E; Irwig, Les; Hersch, Jolyn; Guitera, Pascale; Soyer, Peter; Mar, Victoria; Saw, Robyn PM; Low, Donald; Low, Cynthia; Drabarek, Dorothy; Espinoza, David; Emery, Jon; Murchie, Peter; Thompson, John F; Scolyer, Richard; Azzi, Anthony; Lilleyman, Alister; Bell, Katy J.L.Published 2021Most subsequent new primary or recurrent melanomas might be self-detected if patients are trained to systematically self-examine their skin and have access to timely medical review (patient-led surveillance). Routinely scheduled ...Open AccessPreprint -
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper
Jobson, Dale; Roffey, Benjamin; Best, Renee; Button-Sloan, Alison; Cossio, Danica; Evans, Sue; Shang, Catherine; Moore, Julie; Arnold, Christopher; Mann, Graham; Shackleton, Mark; Soyer, H Peter; Morton, Rachael L; Zalcberg, John; Mar, VictoriaPublished 2022Introduction Australia has the highest incidence of melanoma in the world with variable care provided by a diverse range of clinicians. Clinical quality registries aim to identify these variations in care and provide ...Open AccessArticle -
“Do dialysis decision aids improve treatment decision making?”
Morton, Rachael LPublished 2016-12-15Open AccessPreprint -
Doctors’ recognition and management of melanoma patients’ risk: an Australian population-based study
Madronio, C.M; Armstrong, B.K; Watts, C.G; Goumas, C.; Morton, Rachael L; Curtin, A.; Menzies, S.W; Mann, G.J; Thompson, J.F; Cust, A.EPublished 2016-02-22Background Guidelines recommend that health professionals identify and manage individuals at high risk of developing melanoma, but there is limited population-based evidence demonstrating real-world practices. Objective ...Open AccessArticle -
Economic considerations of patients and caregivers in choosing a dialysis modality
Walker, Rachael C; Howard, Kirsten; Tong, Allison; Palmer, Suetonia C; Marshall, Mark R; Morton, Rachael LPublished 2016-05-01Introduction Broader adoption of home dialysis could lead to considerable cost savings for health services. Globally, however, uptake remains low. The aim of this study was to describe patient and caregiver perspectives ...Open AccessArticle -
Economic evaluations of psychosocial interventions in cancer: A systematic review
Dieng, Mbathio; Cust, Anne E; Kasparian, Nadine A; Mann, Graham J; Morton, Rachael LPublished 2016-01-27Objective: Although the effectiveness of many psychosocial interventions for people with cancer has been established, one barrier to implementation in routine clinical care is a lack of data on cost-effectiveness. We ...Open AccessArticle -
The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review
Greenaway, Christina; Pareek, Manish; Abou Chakra, Clair-Nour; Walji, Moneeza; Makarenko, Iuliia; Alabdulkarim, Balqis; Hogan, Catherine; McConnell, Ted; Scarfo, Brittany; Christensen, Robin; Tran, Anh; Rowbotham, Nick; Noori, Teymur; van der Werf, Marieke J; Pottie, Kevin; Matteelli, Alberto; Zenner, Dominik; Morton, Rachael LPublished 2018The foreign-born population make up an increasing and large proportion of tuberculosis (TB) cases in European Union/European Economic Area (EU/EEA) low-incidence countries and challenge TB elimination efforts. Methods: We ...Open AccessArticle -
Essential inputs for studies of cost-effectiveness analysis in melanoma
Morton, Rachael LPublished 2014-12-18Health-related quality of life, measured in either ‘utilities’ or ‘disability weights’ is an essential component of cost-effectiveness analysis and burden of disease studies.Open AccessArticle -
Essential inputs for studies of cost-effectiveness analysis in melanoma
Morton, Rachael LPublished 2014-12-18Not applicableOpen AccessArticle -
eTRIO trial: study protocol of a randomised controlled trial of online education modules to facilitate effective family caregiver involvement in oncology
Juraskova, Ilona; Laidsaar-Powell, R; Keast, Rachael; Schofield, Penelope; Costa, Daniel SJ; Kay, Judy; Turner, Sandra; Koczwara, Bogda; Saunders, Christobel; Jefford, Michael; Yates, Pasty; Boyle, Frances; White, Kate; Miller, Annie; Morton, Rachael L; Butt, Zoe; Butow, PhyllisPublished 2021Objective Informal family caregivers play a crucial role in cancer care. Effective caregiver involvement in cancer care can improve both patient and caregiver outcomes. Despite this, interventions improving the caregiver ...Open AccessArticle -
Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
Drabarek, Dorothy; Habgood, Emily; Janda, Monika; Hersch, Jolyn; Ackermann, Deonna; Low, Don; Low, Cynthia; Morton, Rachael L; Dieng, Mbathio; Cust, Anne E; Morgan, Adelaide; Smith, Elloise; Bell, Katy L JPublished 2022Background: Current clinician-led melanoma surveillance models require frequent routinely scheduled clinic visits, with associated travel, cost, and time burden for patients. Patient-led surveillance is a new model of ...Open AccessArticle -
Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
Drabarek, Dorothy; Habgood, Emily; Janda, Monika; Hersch, Jolyn; Ackermann, Deonna M; Low, Don; Low, Cynthia; Morton, Rachael L; Dieng, Mbatho; Cust, Anne E; Morgan, Adelaide; Smith, Elloise; Bell, Katy J.L.Published 2022Current clinician-led melanoma surveillance models require frequent routinely scheduled clinic visits, with associated travel, cost, and time burden for patients. Patient-led surveillance is a new model of follow-up care ...Open AccessArticle -
Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals
Rychetnik, Lucie; McCaffery, Kirsten; Morton, Rachael L; Thompson, John; Menzies, Scott; Irwig, LesPublished 2012-10-22BACKGROUND: There is limited evidence on the relative effectiveness of different follow-up schedules for patients with AJCC stage I or II melanoma, but less frequent follow-up than is currently recommended has been proposed. ...Open AccessArticle -
How often do patients with localized melanoma attend follow-up at a specialist center?
Memari, Niloofar; Hayen, Andrew; Bell, Katy J.L.; Rychetnik, Lucie; Morton, Rachael L; McCaffery, Kirsten; Thompson, John F; Irwig, Les; Turner, Robin MPublished 2015Post-treatment follow-up for patients with American Joint Committee on Cancer (AJCC) stage I/II melanoma is believed to be important for early detection of disease recurrence and new primary melanomas, but comes with costs ...Open AccessArticle -
Impact from point of care devices on emergency department patient processing times compared to central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis
Asha, SE; Chan, AC; Walter, E; Kelly, PJ; Morton, Rachael L; Ajami, A; Wilson, RD; Honneyman, DPublished 2013-06-07Open AccessArticle -
The impact of socio-economic status on melanoma clinical trial participation: an observational cohort study from Australia.
Lee, J; Haydu, L; Thompson, JF; Morton, Rachael LPublished 2014-01-01Low socio-economic status (SES) is reported to be a barrier to participation in cancer clinical trials due to out-of-pocket costs associated with trial participation, logistical barriers to attend screening services in ...Open AccessArticle -
Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review
Blood, Zachary; Tran, Anh; Caleo, Lauren; Saw, Robyn; Dieng, Mbathio; Shakleton, Mark; Soyer, H Peter; Arnold, Chris; Mann, Graham; Morton, Rachael LPublished 2021Abstract Objectives To identify patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) in clinical quality registries, for people with cutaneous melanoma, to inform a new Australian ...Open AccessArticle
Sort by:
Title A-Z